Oxazolidine derivative ameliorates diet-induced non-alcoholic fatty liver disease by modulating PI3K/AKT signaling and metabolic homeostasis.
- DOI
- 10.1016/j.bcp.2026.118451
- Published
- 2026-09-09
- Container
- Biochem Pharmacol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118451,
title = {Oxazolidine derivative ameliorates diet-induced non-alcoholic fatty liver disease by modulating PI3K/AKT signaling and metabolic homeostasis.},
author = {S P RRN and Devadoss T and Chitra V and Almutairi BO and Almutairi MH and Balasubramanian B and Arasu MV and Kumaradoss KM and Palaniappan S and Raja Namasivayam SK and Arockiaraj J.},
year = {2026},
journal = {Biochem Pharmacol},
doi = {10.1016/j.bcp.2026.118451},
url = {https://doi.org/10.1016/j.bcp.2026.118451}
}RIS
TY - JOUR TI - Oxazolidine derivative ameliorates diet-induced non-alcoholic fatty liver disease by modulating PI3K/AKT signaling and metabolic homeostasis. AU - S P RRN AU - Devadoss T AU - Chitra V AU - Almutairi BO AU - Almutairi MH AU - Balasubramanian B AU - Arasu MV AU - Kumaradoss KM AU - Palaniappan S AU - Raja Namasivayam SK AU - Arockiaraj J. PY - 2026 JO - Biochem Pharmacol DO - 10.1016/j.bcp.2026.118451 UR - https://doi.org/10.1016/j.bcp.2026.118451 ER -
APA
RRN, S. P., T, D., V, C., BO, A., MH, A., B, B., MV, A., KM, K., S, P., SK, R. N., & J., A. (2026). Oxazolidine derivative ameliorates diet-induced non-alcoholic fatty liver disease by modulating PI3K/AKT signaling and metabolic homeostasis.. Biochem Pharmacol. https://doi.org/10.1016/j.bcp.2026.118451
Source records
- europe-pmc · retrieved 2026-09-25T12:24:03.436Z